Snir, Y., Leibovitzh, H., Leibovici‐Weissman, Y., Vilkin, A., Cohen, A. D., Shochat, T., . . . Levi, Z. (2021). Dose‐dependent association of proton pump inhibitors use with gastric intestinal metaplasia among Helicobacter pylori‐positive patients. United European Gastroenterol J.
Chicago Style CitationSnir, Yifat, et al. "Dose‐dependent Association of Proton Pump Inhibitors Use With Gastric Intestinal Metaplasia Among Helicobacter Pylori‐positive Patients." United European Gastroenterol J 2021.
Cita MLASnir, Yifat, et al. "Dose‐dependent Association of Proton Pump Inhibitors Use With Gastric Intestinal Metaplasia Among Helicobacter Pylori‐positive Patients." United European Gastroenterol J 2021.
Atenció: Aquestes cites poden no estar 100% correctes.